Harrison, C. N., Schaap, N., Vannucchi, A. M., Kiladjian, J., Jourdan, E., Silver, R. T., . . . Mesa, R. A. (2020). Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure. Am J Hematol.
Stile di citazione ChicagoHarrison, Claire N., et al. "Fedratinib in Patients With Myelofibrosis Previously Treated With Ruxolitinib: An Updated Analysis of the JAKARTA2 Study Using Stringent Criteria for Ruxolitinib Failure." Am J Hematol 2020.
Citazione MLAHarrison, Claire N., et al. "Fedratinib in Patients With Myelofibrosis Previously Treated With Ruxolitinib: An Updated Analysis of the JAKARTA2 Study Using Stringent Criteria for Ruxolitinib Failure." Am J Hematol 2020.